医学
心房颤动
冲程(发动机)
地高辛
华法林
左心耳阻塞
心脏病学
导管消融
内科学
人口
心房颤动的处理
达比加群
心力衰竭
工程类
环境卫生
机械工程
作者
Annabelle Santos Volgman,Gatha G. Nair,Radmila Lyubarova,Faisal M. Merchant,Pamela Kay Mason,Anne B. Curtis,NANETTE KASS WENGER,Neelum T. Aggarwal,James N. Kirkpatrick,Emelia J. Benjamin
标识
DOI:10.1016/j.jacc.2021.10.037
摘要
The prevalence of atrial fibrillation (AF) is increasing as the population ages. AF treatment-related complications also increase markedly in older adults (defined as ≥75 years of age for this review). The older AF population has a high risk of stroke, bleeding, and death. Syncope and fall-related injuries are the most common reasons for nonprescription of oral anticoagulation (OAC), and are more common in older adults when OACs are used with antiarrhythmic drugs. Digoxin may be useful for rate control, but associations with increased mortality limit its use. Beyond rate and rhythm control considerations, stroke prophylaxis is critical to AF management, and the benefits of direct OACs, compared with warfarin, extend to older adults. Invasive procedures such as AF catheter ablation, pacemaker implantation/atrioventricular junction ablation, and left atrial appendage occlusion may be useful in appropriately selected cases. However, older adults have generally been under-represented in clinical trials.
科研通智能强力驱动
Strongly Powered by AbleSci AI